%0 Journal Article %T Precise theranostic nanomedicines for inhibiting vulnerable atherosclerotic plaque progression through regulation of vascular smooth muscle cell phenotype switching %A Dong Han %A Feng Cao %A Jiangwei Chen %A Jing Feng %A Li Fan %A Meiling Ding %A Meng-Qi Xu %A Miaomiao Fan %A Sai Ma %A Seyed Mohammad Motevalli %A Weisheng Guo %A Xing-Jie Liang %A Ya Qiu %A Yabin Wang %J Theranostics %D 2018 %I Ivyspring International Publisher %R 10.7150/thno.24364 %X Coronary heart disease is a prevalent and fatal killer caused by vulnerable atherosclerotic plaques (VASPs). However, the precise detection and treatment of VASPs remains a difficult challenge. Here, we present the development of noninvasive human serum albumin (HSA)-based theranostic nanomedicines (NMs) for the specific diagnosis and effective therapy of VASPs. %K atherosclerosis %K theranostic nanomedicines %K sirtuin 1 %K osteopontin %K vascular smooth muscle cells %U http://www.thno.org/v08p3693.htm